Results 41 to 50 of about 12,045 (194)

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications

Antimicrobial Stewardship & Healthcare Epidemiology, 2022
Background: Outpatient parenteral antimicrobial therapy (OPAT) is used in the outpatient setting to treat infectious conditions that require a prolonged course of antimicrobials.
Christina Kaul, Jenny Yang, Matthew Haller, Sadie Solomon, Yaojie Wang, Rong Wu, Yu Meng, Robert Pitts, Michael Phillips   +8 more
doaj   +1 more source

Adverse events leading to discontinuation of daptomycin versus vancomycin in outpatient parenteral antimicrobial therapy: a retrospective cohort study. [PDF]

JAC Antimicrob Resist
Objectives To compare the adverse event rates between daptomycin and vancomycin in the outpatient parenteral antimicrobial therapy (OPAT) setting. Methods This was a retrospective cohort study of patients treated with vancomycin or daptomycin in OPAT ...
Lanier K, Jawanda J, Cid A.
europepmc   +2 more sources

Consulting with children and parents to co-create resources about receiving paediatric outpatient parenteral antimicrobial therapy (OPAT)

, 2022
Consulting with children and parents to co-create resources about receiving paediatric outpatient parenteral antimicrobial therapy ...
SARON, HOLLY; id_orcid
core   +1 more source

Outpatient parenteral antimicrobial therapy

, 2018
Outpatient parenteral antibiotic therapy enables patients to receive intravenous antibiotics without having to be an inpatient. Outpatient parenteral antibiotic therapy can be delivered in an outpatient setting or in the patient's own home by a visiting
Richard Bellamy
core   +1 more source

THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA

Исследования и практика в медицине, 2015
:Acute pyelonephritis is one of the common diseases both in outpatient and in the hospital practice. The leading causative agent of this disease is E. coli.
A. D. Kaprin, A. A. Kostin, S. V. Popov
doaj   +1 more source

Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan

International Journal of Infectious Diseases, 2020
Objectives: The infectious diseases team at Kameda Medical Center, Japan, implemented a new outpatient parenteral antimicrobial therapy (OPAT) program in July 2012 and expanded the program with the support of home care services.
Ryota Hase, Yoshiaki Yokoyama, Hiroyuki Suzuki, Shunsuke Uno, Takahiro Mikawa, Daisuke Suzuki, Kiyoharu Muranaka, Naoto Hosokawa   +7 more
doaj   +1 more source

A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion

Therapeutic Advances in Infectious Disease, 2023
Outpatient parenteral antimicrobial therapy (OPAT) has been widely used in clinical practice for many decades because of its associated cost savings, reductions in inpatient hospital days, and decreases in hospital-associated infections.
Amy L. Van Abel, Lindsey M. Childs-Kean, Kelsey L. Jensen, Ryan P. Mynatt, Keenan L. Ryan, Christina G. Rivera   +5 more
doaj   +1 more source

Outpatient Parenteral Antimicrobial Therapy Practice in United Kingdom: A Single-center Experience

Oman Medical Journal, 2022
Objectives: This study sought to analyze the outpatient parenteral antimicrobial therapy (OPAT) services provided by a tertiary hospital, in terms of types and duration of antimicrobials administered, and assess whether these services were in line with ...
Damini Kesharwani, Anushruti Bista, Hardeep Singh, Ashwin Unnithan, Gautam Das, Sarah Bristoll, Nicki Lewis, Nadhim Alnoori   +7 more
doaj   +1 more source

Outpatient Parenteral Antimicrobial Therapy in Pediatric Patients

Journal of Behçet Uz Children's Hospital
Objective: Outpatient parenteral antimicrobial therapy (OPAT) has been developed as an alternative approach to hospital stay for the effective treatment of infections requiring long-term therapy. The aim of this study is to evaluate the clinical outcomes
Hıncal Özbakır, Deniz Ergün, Pelin Kaçar, Berna Kahraman Çetin, Arife Özer, Çağla Özbakır, Gizem Güner Özenen, Aybüke Akaslan Kara, Dilek Orbatu, Nuri Bayram, İlker Devrim   +10 more
doaj   +1 more source

Exploring the advancements of Australian OPAT

Therapeutic Advances in Infectious Disease, 2023
Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes.
Tony Lai, Horst Thiele, Benjamin A. Rogers, Nadine Hillock, Suman Adhikari, Alexander McNamara, Matthew Rawlins   +6 more
doaj   +1 more source